Mobile Health Promises To Uproot, Uplift Medical Devices
This article was originally published in Start Up
You may also be interested in...
START-UP’s 2013 Life Science Venture Capital Survey: Lights, Even Exits, At The End Of A Dark Tunnel
Our third annual survey of institutional and corporate VCs arrives as life science investing reaches a crossroads. Public markets are gung ho for new biotech companies, lifting the spirits of a subset of our respondents, but VCs still face big hurdles to raise new funds.
The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.
Large numbers of patients with chronic wounds haven’t responded to existing treatments, and their open wounds can have dire consequences. The suffering of patients, the failures of past remedy attempts, and new financial pressures on hospitals have medtech entrepreneurs and venture investors focused on finding better solutions to wound care.